Rockwell Medical (RMTI) Current Leases (2010 - 2026)
Rockwell Medical (RMTI) posted Current Leases of $468000.0 for Q1 2026, little changed on a QoQ basis from $469000.0 in Q4 2025, and down 67.88% year-over-year from $1.5 million in Q1 2025.
Rockwell Medical (RMTI) Current Leases (2010 - 2026) Analysis & Trends
Rockwell Medical's Current Leases history runs 12 years deep, the most recent figure standing at $468000.0 for Q1 2026.
- Quarterly Current Leases fell 67.88% year-over-year to $468000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $468000.0 (down 67.88% YoY) and the FY2025 annual result came in at $469000.0, down 21.7% from the prior year.
- Current Leases was $468000.0 for Q1 2026 at Rockwell Medical, roughly flat from $469000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.6 million in Q2 2023 and bottomed at $461000.0 in Q3 2025.
- A 5-year average of $940142.9 and a median of $593000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases sank 73.95% — and 2025, when it soared 157.42%.
- Rockwell Medical's Current Leases stood at $522000.0 in 2022, then grew by 6.9% to $558000.0 in 2023, then rose by 7.35% to $599000.0 in 2024, then slipped by 21.7% to $469000.0 in 2025, then fell by 0.21% to $468000.0 in 2026.
- Business Quant data shows RMTI's Current Leases at $468000.0 in Q1 2026, $469000.0 in Q4 2025, and $461000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 468,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 468,000.00 |
| Dec 31, 2025 | 469,000.00 |
| Sep 30, 2025 | 461,000.00 |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 599,000.00 |
| Sep 30, 2024 | 587,000.00 |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 566,000.00 |
| Dec 31, 2023 | 558,000.00 |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 522,000.00 |
| Dec 31, 2021 | 2.00 Mn |
| Dec 31, 2020 | 1.17 Mn |
| Sep 30, 2020 | 1.16 Mn |
| Jun 30, 2020 | 1.34 Mn |
| Mar 31, 2020 | 1.35 Mn |
| Dec 31, 2019 | 1.49 Mn |